BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Lupin Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500257
ISIN Demat
INE326A01037
Book Value (Rs)
659.0470742
NSE Symbol
LUPIN
Divident Yield %
0.72
Market Cap
(Rs In Cr.)
113,933
P/E (TTM)
18.89
EPS (TTM)
131.91
Face Value
(Rs)
2
Date Heading
09-Jul-26 Lupin to convene AGM
08-Jul-26 Lupin allots 2,358 equity shares under ESOP
08-Jul-26 Lupin fixes record date for final dividend
01-Jul-26 Lupin receives EMA approval for Pediatric Indication of NaMuscla
29-Jun-26 Lupin gains as receives USFDA tentative nod for generic Xtandi tablets
26-Jun-26 Lupin receives USFDA tentative approval for Enzalutamide Tablets
26-Jun-26 Lupin gets USFDA tentative nod for generic Xtandi tablets
18-Jun-26 Indices trade sideways in early trade; breadth strong
18-Jun-26 Lupin gains after launching generic hypertension drug in the US
17-Jun-26 Lupin launches generic hypertension drug in the US
08-Jun-26 Lupin partners with Spain’s ERN for launch of asthma, COPD inhaler Luf
08-Jun-26 Lupin launches Luforbec® inhaler in Spain
05-Jun-26 Lupin gains after receiving USFDA nod for Ranluspec
03-Jun-26 Lupin and alliance partner Natco receive USFDA approval for Eribulin M
28-May-26 Lupin receives Establishment Inspection Report for its Ankleshwar unit
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)